ELI LILLY AND COMPANY Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year (Deprecated 2017-01-31)
ELI LILLY AND COMPANY (LLY) reported Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year (Deprecated 2017-01-31) of $20.00 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-07-28.
Discontinued › Notes
us-gaap:DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear · last filed 2017-07-28
- ELI LILLY AND COMPANY defined benefit plans, estimated future employer contributions in current fiscal year (deprecated 2017-01-31) for the quarter ending 2017-06-30 was -$15.00M.
- ELI LILLY AND COMPANY defined benefit plans, estimated future employer contributions in current fiscal year (deprecated 2017-01-31) for the quarter ending 2017-03-31 was $35.00M, a 16.67% increase year-over-year.
- ELI LILLY AND COMPANY defined benefit plans, estimated future employer contributions in current fiscal year (deprecated 2017-01-31) for the quarter ending 2016-09-30 was -$10.00M.
- ELI LILLY AND COMPANY defined benefit plans, estimated future employer contributions in current fiscal year (deprecated 2017-01-31) for the quarter ending 2016-06-30 was -$5.00M.
| Period end | Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year (Deprecated 2017-01-31) 3 month | Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year (Deprecated 2017-01-31) 6 month | Defined Benefit Plans, Estimated Future Employer Contributions in Current Fiscal Year (Deprecated 2017-01-31) 9 month |
|---|---|---|---|
| 2017-06-30 | -$15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $20.00M 10-Q · filed 2017-07-28 | |
| 2017-03-31 | $35.00M 10-Q · filed 2017-05-01 | ||
| 2016-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$15.00M derived: sum of 2 quarters · filed 2016-10-28 | $15.00M 10-Q · filed 2016-10-28 |
| 2016-06-30 | -$5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $25.00M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $30.00M 10-Q · filed 2016-04-29 | ||
| 2015-09-30 | -$5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | -$20.00M derived: sum of 2 quarters · filed 2015-10-30 | $10.00M 10-Q · filed 2015-10-30 |
| 2015-06-30 | -$15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $15.00M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $30.00M 10-Q · filed 2015-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |